1. Home
  2. ICLR vs TOL Comparison

ICLR vs TOL Comparison

Compare ICLR & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICLR
  • TOL
  • Stock Information
  • Founded
  • ICLR 1990
  • TOL 1967
  • Country
  • ICLR Ireland
  • TOL United States
  • Employees
  • ICLR N/A
  • TOL N/A
  • Industry
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • TOL Homebuilding
  • Sector
  • ICLR Health Care
  • TOL Consumer Discretionary
  • Exchange
  • ICLR Nasdaq
  • TOL Nasdaq
  • Market Cap
  • ICLR 11.4B
  • TOL 9.8B
  • IPO Year
  • ICLR 1998
  • TOL N/A
  • Fundamental
  • Price
  • ICLR $128.72
  • TOL $102.19
  • Analyst Decision
  • ICLR Buy
  • TOL Buy
  • Analyst Count
  • ICLR 12
  • TOL 16
  • Target Price
  • ICLR $204.18
  • TOL $139.13
  • AVG Volume (30 Days)
  • ICLR 1.6M
  • TOL 1.8M
  • Earning Date
  • ICLR 07-23-2025
  • TOL 05-20-2025
  • Dividend Yield
  • ICLR N/A
  • TOL 0.96%
  • EPS Growth
  • ICLR 11.53
  • TOL N/A
  • EPS
  • ICLR 9.19
  • TOL 13.50
  • Revenue
  • ICLR $8,192,621,999.00
  • TOL $10,659,614,000.00
  • Revenue This Year
  • ICLR N/A
  • TOL N/A
  • Revenue Next Year
  • ICLR $2.34
  • TOL $3.41
  • P/E Ratio
  • ICLR $14.18
  • TOL $7.72
  • Revenue Growth
  • ICLR N/A
  • TOL 1.59
  • 52 Week Low
  • ICLR $125.10
  • TOL $86.67
  • 52 Week High
  • ICLR $347.72
  • TOL $169.52
  • Technical
  • Relative Strength Index (RSI)
  • ICLR 37.40
  • TOL 46.07
  • Support Level
  • ICLR $127.96
  • TOL $101.92
  • Resistance Level
  • ICLR $132.96
  • TOL $107.95
  • Average True Range (ATR)
  • ICLR 4.04
  • TOL 2.63
  • MACD
  • ICLR 0.75
  • TOL -0.36
  • Stochastic Oscillator
  • ICLR 22.44
  • TOL 3.03

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

About TOL Toll Brothers Inc.

Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US It has its headquarters in Horsham, Pennsylvania.

Share on Social Networks: